Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.94 |
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 6/20 | 0.55 |
| ▸ | PPARD | Q03181 | 6/20 | 0.55 |
| ▸ | PPARA | Q07869 | 6/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2837455 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL4521988 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL4538714 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL4531504 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL4533686 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL202758 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL4533669 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL173209 | 1.00 | — | — | |
| SCHEMBL4536912 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 | |
| SCHEMBL1954234 | 1.00 | FOLH1 (0.94) | FOLH1TSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118895120-A | Optical material for anti-counterfeit label, preparation method thereof and anti-counterfeit label | 兰州大学 | 2024-11-05 | — | — | CN | claimed |
| CN-116271074-A | Tumor targeting therapeutic drug with dual therapeutic mechanism | 东曜药业有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20170087640-A1 | PHOTOLUMINESCENT GOLD NANOPARTICLES AND MANUFACTURING METHOD THEREOF | HWU, YEU-KUANG (TW) | 2017-03-30 | — | — | US | claimed |
| CN-118895120-A | Optical material for anti-counterfeit label, preparation method thereof and anti-counterfeit label | 兰州大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-116271074-B | Tumor targeting therapeutic drug with dual therapeutic mechanism | 东曜药业有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-116271074-A | Tumor targeting therapeutic drug with dual therapeutic mechanism | 东曜药业有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4188984-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2023-06-07 | — | — | EP | disclosed |
| US-20230165891-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2023-06-01 | — | — | US | disclosed |
| WO-2022023335-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2022-02-03 | — | — | WO | disclosed |
| EP-2862936-B1 | OXIDOREDUCTASE REACTION CONTROL USING AMINO SUBSTITUTED BIPYRIDINIUM COMPOUNDS | AMANO ENZYME INC (JP) | 2021-12-22 | — | — | EP | disclosed |
| US-9777299-B2 | Oxidoreductase reaction control and use thereof | AMANO ENZYME INC. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20170087640-A1 | PHOTOLUMINESCENT GOLD NANOPARTICLES AND MANUFACTURING METHOD THEREOF | HWU, YEU-KUANG (TW) | 2017-03-30 | — | — | US | disclosed |
| US-9378962-B2 | Nonvolatile semiconductor storage device having a charge storage layer that includes metal grains | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20150176037-A1 | OXIDOREDUCTASE REACTION CONTROL AND USE THEREOF | AMANO ENZYME INC. (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-2862936-A1 | OXIDOREDUCTASE REACTION CONTROL AND USE THEREOF | Amano Enzyme Inc. (JP) | 2015-04-22 | — | — | EP | disclosed |
| US-20130242670-A1 | NONVOLATILE SEMICONDUCTOR STORAGE DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20090123516-A1 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-05-14 | — | — | US | disclosed |
| WO-2007019478-A2 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165891-A1 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | SELPLG, DDOST, CD2BP2 | FOLH1 1788/4885TSHR 4521/4885LMNA 2975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.